BAM
DGX icon

Baring Asset Management’s Quest Diagnostics DGX Stock Holding History

Baring Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.26M Buy
13,456
+707
+6% +$75.1K 0.07% 139
2017
Q2 		$1.42M Sell
12,749
-936
-7% -$99K 0.09% 117
2017
Q1 		$1.34M Buy
13,685
+11,285
+470% +$1.08M 0.09% 133
2016
Q4 		$221K Buy
+2,400
New +$207K 0.02% 171

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Baring Asset Management's DGX Position: Q3 2017 in Review

Baring Asset Management increased its Quest Diagnostics (DGX) stake by 5.5% in Q3 2017, buying an estimated $75.1K and bringing the position to 13,456 shares worth $1.26M. The position accounts for 0.07% of the portfolio, ranked #139.

Baring Asset Management first reported a position in DGX in Q4 2016 and has held it in 4 quarters since. The position peaked at $1.42M in Q2 2017. 616 funds tracked by Wall St. Rank hold DGX as of Q3 2017.

  • Baring Asset Management held 13,456 shares of Quest Diagnostics worth $1.26M as of Q3 2017.
  • Baring Asset Management bought 707 Quest Diagnostics shares in Q3 2017, an estimated $75.1K.
  • Quest Diagnostics made up 0.07% of Baring Asset Management's portfolio in Q3 2017, its #139 holding.
  • Baring Asset Management first reported a position in Quest Diagnostics in Q4 2016 and has held it in 4 quarters since.
  • Baring Asset Management's Quest Diagnostics position peaked at $1.42M in Q2 2017.
  • 616 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2017.

Based on Baring Asset Management's 13F filing for Q3 2017, filed 26 Oct 2017.